文献速递产科母胎医学

双胎输血综合征激光手术前短宫颈的早产预防干预

Interventions to prevent preterm delivery in women with short cervix before fetoscopic laser surgery for twin-twin transfusion syndrome.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-13

本研究为五个北美胎儿治疗网络中心的前瞻性数据二次分析,纳入255例双胎输血综合征(TTTS)且激光手术前宫颈长度<30 mm的单绒毛膜双羊膜囊双胎孕妇,比较期待管理、阴道孕酮、子宫托、宫颈环扎及联合治疗对激光至分娩间隔的影响。结果显示各组间隔无显著差异,但环扎与间隔缩短13天相关,阴道孕酮与28周前分娩风险降低相关,期待管理下32周前分娩风险高达62%。

要点

  • TTTS短宫颈激光术后期待管理下32周前分娩风险为62%。
  • 宫颈环扎与激光至分娩间隔缩短13天相关,不推荐作为二级预防。
  • 阴道孕酮与28周前分娩风险降低相关,但需随机试验验证。

核心结论

  • 在TTTS短宫颈行FLP的孕妇中,未发现能显著改善结局的干预措施,宫颈环扎不应作为二级预防提供。

研究设计与样本

  • 五个NAFTNet中心的前瞻性数据二次分析,纳入255例TTTS短宫颈(<30 mm)行FLP的单绒毛膜双羊膜囊双胎孕妇。

主要发现

  • 151例(59%)期待管理,32例(13%)仅阴道孕酮,21例(8%)仅子宫托,21例(8%)仅宫颈环扎,30例(12%)联合治疗。
  • 联合治疗组既往早产比例高于期待管理组(33% vs 9%;P=0.01)。
  • 子宫托、环扎和联合治疗组平均术前宫颈长度(14-16 mm)短于期待管理和阴道孕酮组(均为22 mm)(P<0.001)。
  • 各组激光至分娩间隔、分娩孕周、活产率或新生儿存活率无显著差异。
  • 阴道孕酮与环扎和联合治疗相比,28周前分娩风险降低(P=0.03)。

关键数值与推荐

  • 术前宫颈长度<30 mm为纳入标准。
  • 期待管理下32周前分娩风险为62%。
  • 阴道孕酮与28周前分娩风险降低相关(P=0.03)。
  • 宫颈环扎与激光至分娩间隔缩短13天相关。

临床怎么用

  • 对于TTTS短宫颈行FLP的孕妇,应告知期待管理下早产风险高,不推荐宫颈环扎作为二级预防。
  • 阴道孕酮可能降低28周前分娩风险,但需与患者充分沟通证据局限性。
  • 亟需大规模随机对照试验确定有效干预措施。

局限性

  • 存在显著潜在混杂因素差异,且可能存在未测量的混杂因素。
  • 为二次分析,非随机对照设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Preoperative short cervical length (CL) remains a major risk factor for preterm birth after laser surgery for twin-twin transfusion syndrome (TTTS), but the optimal intervention to prolong pregnancy remains elusive. The objective of this study was to compare secondary methods for the prevention of preterm birth in twin pregnancies with TTTS undergoing fetoscopic laser photocoagulation (FLP), in the setting of a short cervix at the time of FLP, in five North American Fetal Treatment Network (NAFTNet) centers. METHODS: This was a secondary analysis of data collected prospectively at five NAFTNet centers, conducted from January 2013 to March 2020. Inclusion criteria were a monochorionic diamniotic twin pregnancy complicated by TTTS, undergoing FLP, with preoperative CL < 30 mm. Management options for a short cervix included expectant management, vaginal progesterone, pessary (Arabin, incontinence or Bioteque cup), cervical cerclage or a combination of two or more treatments. Patients were not included if the intervention was initiated solely on the basis of having a twin gestation rather than at the diagnosis of a short cervix. Demographics, ultrasound characteristics, operative data and outcomes were compared. The primary outcome was FLP-to-delivery interval. Propensity-score matching was performed, with each treatment group matched (1:1) to the expectant-management group for CL, in order to estimate the effect of each treatment on the FLP-to-delivery interval. RESULTS: A total of 255 women with a twin pregnancy complicated by TTTS and a short cervix undergoing FLP were included in the study. Of these, 151 (59%) were managed expectantly, 32 (13%) had vaginal progesterone only, 21 (8%) had pessary only, 21 (8%) had cervical cerclage only and 30 (12%) had a combination of treatments. A greater proportion of patients in the combined-treatment group had had a prior preterm birth compared with those in the expectant-management group (33% vs 9%; P = 0.01). Mean preoperative CL was shorter in the pessary, cervical-cerclage and combined-treatment groups (14-16 mm) than in the expectant-management and vaginal-progesterone groups (22 mm for both) (P < 0.001). There was no significant difference in FLP-to-delivery interval between the groups, nor in gestational age at delivery or the rate of live birth or neonatal survival. Vaginal progesterone was associated with a decrease in the risk of delivery before 28 weeks' gestation compared with cervical cerclage and combined treatment (P = 0.03). Using propensity-score matching for CL, cervical cerclage was associated with a reduction in FLP-to-delivery interval of 13 days, as compared with expectant management. CONCLUSIONS: A large proportion of pregnancies with TTTS and a short maternal cervix undergoing FLP were managed expectantly for a short cervix, establishing a high (62%) risk of delivery before 32 weeks in this condition. No treatment that significantly improved outcome was identified; however, there were significant differences in potential confounders and there were also likely to be unmeasured confounders. Cervical cerclage should not be offered as a secondary prevention for preterm birth in twin pregnancies with TTTS and a short cervix undergoing FLP. A large randomized controlled trial is urgently needed to determine the effects of treatments for the prevention of preterm birth in these pregnancies. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Buskmiller C, Bergh EP, Brock C, et al. Interventions to prevent preterm delivery in women with short cervix before fetoscopic laser surgery for twin-twin transfusion syndrome. Ultrasound Obstet Gynecol. 2022. PMID: 34129709. doi:10.1002/uog.23708

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。